Nano Tsunami : New Nanotech Device Could Revolutionize Blood Testing

[OhWiseone]

New Nanotech Device Could Revolutionize Blood Testing

 

Like the small fingerstick devices that have revolutionized management of insulin therapy for people with diabetes, BioSensus, Inc., is developing a rapid and inexpensive monitor for anticoagulant therapy that could make a major difference for millions of patients.

 

It could also send BioSensus over the top as an overnight success in the medical device industry. The company is eying a $1 billion blood coagulation and hemostatic assay market, according to NanoBiotech News, the only weekly, independent news source on the business and science of nanomedicine development.

 

Worldwide, about 6 million people are treated with oral anticoagulant therapy to prevent the formation of blood clots in atrial fibrillation, deep vein thrombosis, heart attack, stroke and other potentially life-threatening conditions. In American hospitals, hundreds of thousands of patients receive intravenous heparin therapy on a temporary basis, to reduce the risk of clots….read the wave www.nano-tsunami.com